These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1770430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activation of the complement system by (1----3)-beta-D-glucans having different degrees of branching and different ultrastructures.
    Suzuki T, Ohno N, Saito K, Yadomae T.
    J Pharmacobiodyn; 1992 Jun; 15(6):277-85. PubMed ID: 1432567
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of clot formation of human plasma by beta-glucans.
    Ohno N, Suzuki T, Saito K, Yadomae T.
    J Pharmacobiodyn; 1990 Sep; 13(9):525-32. PubMed ID: 2084223
    [Abstract] [Full Text] [Related]

  • 5. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
    Sakurai T, Ohno N, Suzuki I, Yadomae T.
    Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
    [Abstract] [Full Text] [Related]

  • 6. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
    Sakurai T, Kaise T, Yadomae T, Matsubara C.
    Eur J Pharmacol; 1997 Sep 10; 334(2-3):255-63. PubMed ID: 9369356
    [Abstract] [Full Text] [Related]

  • 7. Resistance of highly branched (1-->3)-beta-D-glucans to formolysis.
    Ohno N, Terui T, Chiba N, Kurachi K, Adachi Y, Yadomae T.
    Chem Pharm Bull (Tokyo); 1995 Jun 10; 43(6):1057-60. PubMed ID: 7641306
    [Abstract] [Full Text] [Related]

  • 8. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
    Honda S, Sugino H, Asano T, Kakinuma A.
    Immunopharmacology; 1986 Feb 10; 11(1):29-37. PubMed ID: 3957648
    [Abstract] [Full Text] [Related]

  • 9. Biological activities of (1-->3)-beta-D-glucans with reducing glucose side chains.
    Kiho T, Matsushita M, Usui S, Ukai S.
    Biosci Biotechnol Biochem; 1998 Mar 10; 62(3):570-2. PubMed ID: 9571788
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N, Kurachi K, Yadomae T.
    J Pharmacobiodyn; 1987 Sep 10; 10(9):478-86. PubMed ID: 3437391
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro.
    Okazaki M, Adachi Y, Ohno N, Yadomae T.
    Biol Pharm Bull; 1995 Oct 10; 18(10):1320-7. PubMed ID: 8593430
    [Abstract] [Full Text] [Related]

  • 12. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
    Kurachi K, Ohno N, Yadomae T.
    Chem Pharm Bull (Tokyo); 1990 Sep 10; 38(9):2527-31. PubMed ID: 2285987
    [Abstract] [Full Text] [Related]

  • 13. Anticoagulant activity of sulfoalkyl derivatives of curdlan.
    Lee KB, Bae JH, Kim JS, Yoo YC, Kim BS, Kwak ST, Kim YS.
    Arch Pharm Res; 2001 Apr 10; 24(2):109-13. PubMed ID: 11339629
    [Abstract] [Full Text] [Related]

  • 14. Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.
    Suzuki Y, Adachi Y, Ohno N, Yadomae T.
    Biol Pharm Bull; 2001 Jul 10; 24(7):811-9. PubMed ID: 11456123
    [Abstract] [Full Text] [Related]

  • 15. Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.
    Sakurai T, Ohno N, Yadomae T.
    Chem Pharm Bull (Tokyo); 1992 Aug 10; 40(8):2120-4. PubMed ID: 1423766
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice.
    Ohno N, Asada N, Adachi Y, Yadomae T.
    Biol Pharm Bull; 1995 Jan 10; 18(1):126-33. PubMed ID: 7735226
    [Abstract] [Full Text] [Related]

  • 17. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    J Pharmacobiodyn; 1992 Aug 10; 15(8):417-26. PubMed ID: 1479542
    [Abstract] [Full Text] [Related]

  • 18. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
    Suda M, Ohno N, Hashimoto T, Koizumi K, Adachi Y, Yadomae T.
    FEMS Immunol Med Microbiol; 1996 Sep 10; 15(2-3):93-100. PubMed ID: 8880133
    [Abstract] [Full Text] [Related]

  • 19. Mitogenic activity of particulate yeast beta-(1-->3)-D-glucan and its water-soluble derivatives.
    Sandula J, Machová E, Hríbalová V.
    Int J Biol Macromol; 1995 Dec 10; 17(6):323-6. PubMed ID: 8789333
    [Abstract] [Full Text] [Related]

  • 20. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice.
    Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae T.
    Biol Pharm Bull; 1996 Apr 10; 19(4):608-12. PubMed ID: 8860968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.